Kodiak Sciences Inc KOD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -208.8%-59.3pp | -149.5%+58.4pp | -207.9%-67.6pp | -140.3%-31.4pp | -108.9%-24.2pp | |
| Return on assets | -76.4%-9.5pp | -66.9%+6.6pp | -73.6%-12.9pp | -60.7%-8.7pp | -52%-8.8pp | |
| Liquidity | ||||||
| Current ratio | 3.5×-1.2× | 4.7×+2.9× | 1.8×-1.7× | 3.5×-1.1× | 4.6×-2.1× | |
| Quick ratio | 3.5×-1.2× | 4.7×+2.9× | 1.8×-1.7× | 3.5×-1.1× | 4.6×-2.1× | |
| Cash ratio | 3.4×-1.2× | 4.6×+2.9× | 1.7×-1.7× | 3.4×-1.1× | 4.5×-2.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×+0.1× | 0.4×-2.2× | 2.6×+1.7× | 0.9×+0.3× | 0.6×+0.2× | |
| Debt-to-assets | 0.2×0.0× | 0.2×-0.1× | 0.3×0.0× | 0.3×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $1.81-38.7% | $2.96+560% | $0.45-66.3% | $1.33-35.5% | $2.06-27.8% | |
| Valuation | ||||||
| Market capitalization | $2.33B+36.3% | $1.71B+97.4% | $864.69M+354% | $190.48M+29.0% | $147.61M-71.8% | |
| Enterprise value | $2.21B+42.2% | $1.56B+82.0% | $854.85M+464% | $151.52M+98.3% | $76.4M-82.1% | |
| Price / book | 20.8×+9.9× | 10.8×-25.7× | 36.5×+33.8× | 2.7×+1.4× | 1.4×-2.1× | |
| Free cash flow yield | -6.4%+1.6pp | -8%+6.7pp | -14.7%+46.0pp | -60.7%+12.0pp | -72.8%-50.3pp | |
| Earnings yield | -9.9%+3.6pp | -13.5%+11.7pp | -25.1%+79.8pp | -104.9%+24.2pp | -129.1%-95.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Kodiak Sciences Inc's ratios come from?
- Every ratio is computed from Kodiak Sciences Inc's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.